At this year’s SCRS West conference in Scottsdale, Arizona, Clinical.ly joined Tribe Clinical Research to lead a discussion on a topic that impacts every research site, regardless of size, specialty, or technology stack: the importance of technology partnerships.
The session, Co-Creating Clinical Trial Success: Sites & Vendors in Action, explored a simple but often overlooked reality: technology adoption challenges rarely stem from the technology itself. More often, they result from misaligned expectations, unclear ownership, and partnerships that never fully develop beyond the purchasing stage.
As sites continue to evaluate new systems to support growth, compliance, and operational efficiency, it’s worth asking a different question.
Instead of asking, “Which technology should we buy?” perhaps the better question is, “Who should we partner with?”
Moving Beyond Procurement with Technology Partnerships
The clinical research industry often approaches technology selection as a procurement exercise. Sites compare features, evaluate pricing, review demonstrations, and make a decision.
While those factors matter, they rarely determine long-term success.
During our session, we discussed the concept of mutual qualification; the idea that sites and vendors should evaluate one another with the same level of scrutiny and transparency.
The strongest technology implementations happen when both organizations understand:
- Operational readiness
- Available resources
- Capacity for change
- Ownership expectations
When those conversations happen early, implementation becomes significantly smoother. When they don’t, even the most capable technology can struggle to gain adoption.
Implementation Is Where Trust Is Built
Many organizations view implementation as a project plan with a clear finish line. In reality, implementation is often the first real test of the partnership.
Unexpected workflow challenges emerge. Assumptions are challenged. Processes that looked straightforward on paper become more nuanced in practice.
What separates successful implementations from unsuccessful ones isn’t the absence of friction, it’s how both parties respond when friction occurs.
Open communication, regular check-ins, and shared accountability create the foundation for long-term success. Sites and vendors that approach implementation as a collaborative process rather than a transactional handoff tend to achieve stronger outcomes and higher adoption rates.
The Work Doesn’t End at Go-Live
One of the most important discussions during the workshop focused on what happens after implementation.
Too often, organizations treat go-live as the finish line.
In reality, it’s the starting point.
The most successful sites continuously refine workflows, provide feedback, and look for opportunities to improve efficiency. Likewise, the most successful vendors remain engaged, responsive, and invested in their customers’ success long after implementation is complete.
This creates what we described as a “trust flywheel”—a cycle where communication leads to improvements, improvements build trust, and trust creates stronger collaboration moving forward.
What Research Sites Can Take Away
Whether you’re evaluating an eRegulatory platform, implementing eSource, adopting eConsent, or exploring new operational tools, the principles remain the same.
Look beyond features.
Ask how the vendor responds to feedback. Understand what support looks like after go-live. Evaluate whether the relationship feels collaborative or transactional.
Most importantly, choose partners who are willing to learn alongside you.
At Clinical.ly, some of our most impactful product enhancements have come directly from conversations with sites. Features like global templates, operational workflow improvements, and new visibility tools didn’t start as internal roadmaps, they started as customer feedback.
That’s because we believe successful technology adoption isn’t something a vendor delivers to a site. It’s something sites and vendors build together.
A Shared Responsibility for Success
One of the strongest themes to emerge from SCRS West was that creating successful clinical trials requires alignment across the entire ecosystem.
Sites, sponsors, CROs, and technology providers all play a role.
When we prioritize process over tools, trust over transactions, and partnership over procurement, technology becomes more than software. It becomes an enabler of stronger operations, better oversight, and ultimately better outcomes for patients.
Thank you to everyone who joined the discussion in Scottsdale. We appreciated the opportunity to hear your perspectives, share experiences, and continue the conversation around what successful site and technology partnerships truly look like in clinical research.
As always, we’ll keep listening.
Because the best solutions are built with sites, not just for them.
Reach out to us to learn more about how Clinical.ly can help!